Top Clinical Trials companies in India by Free Cash Flow Per Share

This ranking features the top 75 Clinical Trials companies in India ranked by Free Cash Flow Per Share, averaging a Free Cash Flow Per Share of USD 0.15, for February 12, 2025.

India

Clinical Trials
Free Cash Flow Per Share
#
Name
Free Cash Flow Per Share
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
ABBOTINDIA.NS

Abbott India Limited

1

ABBOTINDIA.NS
USD 6.57
March 31, 2024 USD 339.25 -0.02%

India
2
PGHL.NS

Procter & Gamble Health Limited

2

PGHL.NS
USD 1.49
June 30, 2024 USD 60.92 -1.55%

India
3
NEULANDLAB.NS

Neuland Laboratories Limited

3

NEULANDLAB.NS
USD 1.10
March 31, 2024 USD 167.70 3.37%

India
4
SANOFI.NS

Sanofi India Limited

4

SANOFI.NS
USD 1.02
Dec. 31, 2023 USD 61.92 -0.63%

India
5
TORNTPHARM.NS

Torrent Pharmaceuticals Limited

5

TORNTPHARM.NS
USD 1.00
March 31, 2024 USD 36.49 -1.65%

India
6
STAR.NS

Strides Pharma Science Limited

6

STAR.NS
USD 0.77
March 31, 2024 USD 8.39 -1.57%

India
7
LUPIN.NS

Lupin Limited

7

LUPIN.NS
USD 0.72
March 31, 2024 USD 24.79 -1.08%

India
8
PFIZER.NS

Pfizer Limited

8

PFIZER.NS
USD 0.62
March 31, 2024 USD 48.55 -2.16%

India
9
NATCOPHARM.NS

NATCO Pharma Limited

9

NATCOPHARM.NS
USD 0.57
March 31, 2024 USD 14.65 -2.48%

India
10
MANKIND.NS

Mankind Pharma Limited

10

MANKIND.NS
USD 0.53
March 31, 2024 USD 28.60 -0.29%

India
11
METROPOLIS.NS

Metropolis Healthcare Limited

11

METROPOLIS.NS
USD 0.47
March 31, 2024 USD 20.54 -1.93%

India
12
GLAND.NS

Gland Pharma Limited

12

GLAND.NS
USD 0.44
March 31, 2024 USD 16.89 -2.20%

India
13
JBCHEPHARM.NS

J. B. Chemicals & Pharmaceuticals Limited

13

JBCHEPHARM.NS
USD 0.42
March 31, 2024 USD 19.18 0.81%

India
14
CIPLA.NS

Cipla Limited

14

CIPLA.NS
USD 0.41
March 31, 2024 USD 16.67 -0.55%

India
15
GLAXO.NS

GlaxoSmithKline Pharmaceuticals Limited

15

GLAXO.NS
USD 0.39
March 31, 2024 USD 24.47 -2.67%

India
16
ERIS.NS

Eris Lifesciences Limited

16

ERIS.NS
USD 0.31
March 31, 2024 USD 16.07 -4.58%

India
17
APLLTD.NS

Alembic Pharmaceuticals Limited

17

APLLTD.NS
USD 0.29
March 31, 2024 USD 10.15 0.53%

India
18
ZYDUSLIFE.NS

Zydus Lifesciences Limited

18

ZYDUSLIFE.NS
USD 0.28
March 31, 2024 USD 11.02 -2.61%

India
19
BAJAJHCARE.NS

Bajaj HealthCare Limited

19

BAJAJHCARE.NS
USD 0.27
March 31, 2024 USD 7.13 -4.42%

India
20
INDGN.NS

Indegene Limited

20

INDGN.NS
USD 0.27
March 31, 2024 USD 7.07 -1.30%

India
21
DRREDDY.NS

Dr. Reddy's Laboratories Limited

21

DRREDDY.NS
USD 0.26
March 31, 2024 USD 13.95 -1.21%

India
22
IPCALAB.NS

Ipca Laboratories Limited

22

IPCALAB.NS
USD 0.25
March 31, 2024 USD 16.55 -3.58%

India
23
VENUSREM.NS

Venus Remedies Limited

23

VENUSREM.NS
USD 0.25
March 31, 2024 USD 4.07 -0.77%

India
24
THYROCARE.NS

Thyrocare Technologies Limited

24

THYROCARE.NS
USD 0.24
March 31, 2024 USD 8.89 -0.43%

India
25
SOLARA.NS

Solara Active Pharma Sciences Limited

25

SOLARA.NS
USD 0.21
March 31, 2024 USD 6.08 -0.02%

India
26
CONCORDBIO.NS

Concord Biotech Limited

26

CONCORDBIO.NS
USD 0.21
March 31, 2024 USD 25.55 -4.35%

India
27
AARTIDRUGS.NS

Aarti Drugs Limited

27

AARTIDRUGS.NS
USD 0.17
March 31, 2024 USD 4.63 -2.34%

India
28
SYNGENE.NS

Syngene International Limited

28

SYNGENE.NS
USD 0.16
March 31, 2024 USD 8.42 -0.78%

India
29
JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited

29

JAGSNPHARM.NS
USD 0.16
March 31, 2024 USD 2.77 -8.82%

India
30
ORCHPHARMA.NS

Orchid Pharma Limited

30

ORCHPHARMA.NS
USD 0.15
March 31, 2024 USD 14.90 -6.51%

India
31
SUVENPHAR.NS

Suven Pharmaceuticals Limited

31

SUVENPHAR.NS
USD 0.14
March 31, 2024 USD 12.77 -3.16%

India
32
BLISSGVS.NS

Bliss GVS Pharma Limited

32

BLISSGVS.NS
USD 0.14
March 31, 2024 USD 1.71 0.29%

India
33
SMSLIFE.NS

SMS Lifesciences India Limited

33

SMSLIFE.NS
USD 0.14
March 31, 2024 USD 14.23 -0.83%

India
34
NECLIFE.NS

Nectar Lifesciences Limited

34

NECLIFE.NS
USD 0.10
March 31, 2024 USD 0.41 -5.40%

India
35
BIOCON.NS

Biocon Limited

35

BIOCON.NS
USD 0.10
March 31, 2024 USD 4.31 -2.14%

India
36
BALPHARMA.NS

Bal Pharma Limited

36

BALPHARMA.NS
USD 0.09
March 31, 2024 USD 1.20 -5.08%

India
37
FDC.NS

FDC Limited

37

FDC.NS
USD 0.09
March 31, 2024 USD 5.26 -2.10%

India
38
ASTRAZEN.NS

AstraZeneca Pharma India Limited

38

ASTRAZEN.NS
USD 0.08
March 31, 2024 USD 86.25 -0.49%

India
39
JUBLPHARMA.NS

Jubilant Pharmova Limited

39

JUBLPHARMA.NS
USD 0.06
March 31, 2024 USD 11.42 0.31%

India
40
IOLCP.NS

IOL Chemicals and Pharmaceuticals Limited

40

IOLCP.NS
USD 0.03
March 31, 2024 USD 4.33 -0.95%

India
41
GRANULES.NS

Granules India Limited

41

GRANULES.NS
USD 0.03
March 31, 2024 USD 6.50 -2.02%

India
42
MARKSANS.NS

Marksans Pharma Limited

42

MARKSANS.NS
USD 0.01
March 31, 2024 USD 3.05 -1.72%

India
43
THEMISMED.NS

Themis Medicare Limited

43

THEMISMED.NS
USD 0.00
March 31, 2024 USD 2.52 -4.77%

India
44
VAISHALI.NS

Vaishali Pharma Limited

44

VAISHALI.NS
USD 0.00
March 31, 2024 USD 0.18 -4.39%

India
45
WOCKPHARMA.NS

Wockhardt Limited

45

WOCKPHARMA.NS
USD 0.00
March 31, 2024 USD 17.37 -4.65%

India
46
TAKE.NS

TAKE Solutions Limited

46

TAKE.NS
USD 0.00
March 31, 2024 USD 0.13 -0.49%

India
47
MEDICO.NS

Medico Remedies Limited

47

MEDICO.NS
USD 0.00
March 31, 2024 USD 0.79 -11.26%

India
48
SEQUENT.NS

Sequent Scientific Limited

48

SEQUENT.NS
USD -0.00
March 31, 2024 USD 1.79 -0.60%

India
49
SYNCOMF.NS

Syncom Formulations (India) Limited

49

SYNCOMF.NS
USD -0.00
March 31, 2024 USD 0.21 -1.97%

India
50
LAURUSLABS.NS

Laurus Labs Limited

50

LAURUSLABS.NS
USD -0.00
March 31, 2024 USD 7.16 -1.98%

India
Frequently Asked Questions
  • Which Clinical Trials company in India has the highest Free Cash Flow Per Share ?

    The Clinical Trials company in India with the highest Free Cash Flow Per Share is Abbott India Limited (NSE: ABBOTINDIA.NS) at USD 6.57.

  • Which Clinical Trials company in India has the lowest Free Cash Flow Per Share ?

    The Clinical Trials company in India with the lowest Free Cash Flow Per Share is Glenmark Pharmaceuticals Limited (NSE: GLENMARK.NS) at USD -0.49.

SV Wall Street